Psychedelics have received a great deal of attention in recent years, including in discussions about addiction recovery. Some people hope that a profound experience will “flip the switch” or that trauma and substance cravings will suddenly become understandable and solvable. At the same time, particularly in the case of addiction, it is especially important to remain vigilant regarding risks, safety, and realistic expectations. Not because psychedelics are inherently “bad,” but because addiction is often associated with vulnerability in stress regulation, impulse control, mood, and an increased risk of risky behavior.
In this article, we outline the key considerations. We distinguish between what is investigated in scientific research, what people may report as experience, and what practical harm reduction can entail. We do not provide individual medical advice or make promises regarding outcomes. However, we do demonstrate why therapy and proper guidance are essential when addiction is involved.
Why addiction can be an additional risk factor
Addiction is usually not just about the substance itself. Underlying factors often play a role, such as trauma, chronic stress, anxiety, depressive symptoms, ADHD, relationship dynamics, a lack of support, or an environment where use is normal. Physical dependence and withdrawal processes can also be involved. This combination means that a psychedelic experience, which can amplify emotions and memories, can actually have a disruptive effect on some people.
Moreover, “set and setting” carries more weight in cases of vulnerability. Set concerns your mental state, expectations, and resilience. Setting concerns the environment, support, and aftercare. With addiction, there is a greater chance that strong triggers exist, that coping mechanisms have been learned primarily through numbing, or that shame and self-criticism surface quickly. Precisely then, a therapeutic context, involving preparation and integration, is often more important than the experience itself.
Life-threatening withdrawal symptoms: the risk of wanting too fast
An underestimated risk is that someone with an alcohol, benzodiazepine, or opioid dependence stops too abruptly to be “ready” for a session. With some substances, withdrawal symptoms can be severe or even life-threatening. Examples include seizures (epileptic attacks) or delirium during alcohol withdrawal, and serious complications with certain substances or combinations.
Moreover, psychedelics can alter the sensation of physical signals or make them less reliable. A person may suppress symptoms, misinterpret them, or become overconfident. As a result, the severity of withdrawal or dysregulation may be underestimated. In practical terms, this means that the physical withdrawal process and medical risks cannot be “bypassed” by a psychedelic experience. A safe route begins with a realistic assessment of physical dependence and, when necessary, medically supervised detox. That is not a detail, but a basic requirement.
Spiritual bypassing: insights without change
Another pitfall is spiritual bypassing. During a powerful experience, it can feel as if everything is clear: “I saw it, so it is resolved.” It can genuinely feel that way, and such an insight can indeed be valuable. However, addiction recovery usually requires behavior, structure, and support in daily life. Insights are the beginning, not the end.
Without therapy and integration, the same triggers, routines, and social circumstances can remain intact. This creates the risk that someone becomes disappointed when the urge returns, and starts thinking that it “doesn’t work” or that there is something wrong with themselves. Therapy helps translate insights into concrete steps, such as recognizing risk situations, building new coping skills, adjusting boundaries, and repairing relationships.
Shame and self-condemnation can surface more strongly.
Psychedelic experiences can intensify emotions and memories. In people with a history of addiction, shame, guilt, and self-condemnation often lie close to the surface. In a session, this can surface as raw pain, sometimes accompanied by images or beliefs such as “I am broken” or “I do not deserve recovery.”.
Without proper guidance, such an emotional wave can backfire. Someone may be left feeling disoriented afterward and actually feel a greater need for numbing, which can reinforce the pattern of self-medication. Therapy is not an “extra” here, but an important safety factor. Good guidance helps to frame, pace, and integrate difficult content afterward, so that vulnerability does not turn into relapse or isolation.
Substitution behavior: when the 'trip' becomes a new flight
It is often said that classic psychedelics are not physically addictive. That is a relevant distinction, but it does not tell the whole story. People can also become dependent on an experience, a ritual, or a sense of escape. Those prone to addiction may begin to pursue the intensity of a trip as a form of ecstasy or temporary relief.
Then the pattern shifts: no longer the single substance, but the psychedelic experience becomes the new “answering machine” to stress, emptiness, or anxiety. The risk is greater with unsupervised use, with repeated dosing without integration, or when someone uses the experience to avoid emotions rather than process them. Therapy helps to understand the function of use: what are the benefits, what are the costs, and which alternatives are feasible in the long term?
Unrealistic expectations and miracle cure thinking
Media attention can create the impression that psychedelics offer a quick fix. Some anecdotal stories sound spectacular, and that can provide hope. Hope is valuable, but miracle cure thinking can also cause harm. If a session does not immediately lead to abstinence or “no more cravings,” it can be demotivating. It can even undermine confidence in proven, multi-step recovery processes.
In research into psychedelics in therapeutic contexts, the emphasis lies precisely on the whole: screening, preparation, guided session(s), and integration. The experience is a component, not a standalone trick. With addiction, it is often more realistic to think in terms of: better insight into triggers, greater emotional accessibility, increased motivation for recovery, or the ability to work through underlying trauma. These are possible processes, not guarantees.
Why therapy and integration can make a difference
Therapy is essential because addiction is often a combination of biology, psychology, and context. A psychedelic experience can expose themes, but therapy makes them workable. Specifically, therapeutic guidance can help with:
Developing a safe plan regarding substance use, triggers, and relapse prevention, including practical agreements and support structures.
Investigating the function of use, for example, numbing, control, reward, connection, or the avoidance of trauma-related feelings.
Practicing new coping skills such as emotion regulation, boundaries, stress reduction, and communication.
Integration: giving meaning to what has been experienced and translating that into achievable behavioral steps, a weekly rhythm, and choices in relationships and the environment.
It is also important to note that “therapy” can be broad: addiction care, trauma therapy, group therapy, systemic therapy, and support through peers or recovery groups. What is appropriate varies by person and situation. A good professional will generally not only look at the experience, but at the entire recovery process.
MDMA, therapy, and practice: what is and isn't allowed
MDMA is being investigated in scientific studies, including in combination with psychotherapy, with special attention to safety, dosage, screening, and aftercare. Outside of research, reality is more complex. Therefore, it is important to state factually that MDMA sessions can currently only be discussed within scientific research or in clinical practice in a harm-reduction context. In practice, this means that the focus lies on risk mitigation, preparation, setting, contraindications, and integration, not on making medical treatment recommendations or promising a cure.
Anyone considering working with MDMA-like processes while addiction plays a role would often do well to be extra careful with screening, discussing substance history, and organizing aftercare. In cases of physical dependence or complex comorbidity, professional (addiction) care can be a necessary first step.
More context regarding the risks of psychedelics for addiction can also be found in the source where these themes are discussed: https://trip-forum.nl/qa/risicos-psychedelica-bij-verslavingen/.
When extra caution is advisable
While it is not possible to conduct an individual assessment, there are situations where extra caution is warranted, for example: recent detox or unstable abstinence, poly-use, a history of severe dysregulation, limited support from the environment, or intense shame and self-hatred that could escalate quickly. Medication, physical health, and mental health history may also be relevant. These are topics to discuss with a qualified healthcare professional.
In this context, harm reduction means minimizing risks as much as possible, taking no rush, and letting the recovery process guide rather than the experience. This can sometimes also mean that not having a session (for now) is the wisest choice.
Conclusion
Psychedelics and addiction is a combination that requires nuance. Potential insights can be valuable, but risks such as dangerous withdrawal, spiritual bypassing, shame activation, substitution behavior, and unrealistic expectations make clear guidance and therapy all the more important. Those who still wish to explore a course of action would do well to prioritize safety, preparation, and integration, and not expect quick fixes.
If you would like to explore support in a harm-reduction context, you can read how registration works via https://mdmatherapie.nl/aanmelden-mdma-sessie/. This is not a medical treatment and there is no guarantee of an outcome, but it can help to carefully discuss your situation and determine what is appropriate and responsible.
